Mycophenolate sodium and Recombinate
Determining the interaction of Mycophenolate sodium and Recombinate and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: mycophenolic acid
Brand name: Myfortic
Synonyms: Mycophenolic acid, Mycophenolate Tablets Delayed Release
Generic Name: antihemophilic factor
Brand name: Advate, Adynovate, Afstyla, Eloctate with Fc Fusion Protein, Helixate FS, Kogenate FS, Kovaltry, Novoeight, Nuwiq, Recombinate, Xyntha, Hemofil-M, Koate-DVI, Monoclate-P, Jivi, Obizur
Synonyms: Recombinate (recombinant)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Mycophenolate sodium-Recombinate recombinant
- Mycophenolate sodium-Recombivax
- Mycophenolate sodium-Recombivax HB
- Mycophenolate sodium-Recombivax HB Adult
- Mycophenolate sodium-Recombivax HB Dialysis Formulation
- Mycophenolate sodium-Recombivax HB Pediatric/Adolescent
- Recombinate-Mycophenolate Suspension
- Recombinate-Mycophenolate Tablets
- Recombinate-Mycophenolate Tablets Delayed Release
- Recombinate-Mycophenolic acid
- Recombinate-Mycophenolic Acid Delayed-Release Tablets
- Recombinate-Mycophenolic Acid Tablets